Abstract
We investigated the relationships between the degradation of basement membrane underlying superficial urothelial carcinomas, including carcinoma in situ and the functional p53 loss caused by inactivation of p53 and the overexpression of mdm2 oncoprotein. Nuclear accumulations of p53 and mdm2 were examined immunohistochemically for 60 transitional cell carcinomas (primary lesions) and 13 accompanying (concomitant) carcinoma in situ lesions. Degradation of the basement membrane was defined as the reduction or total loss of type IV collagen expression. Whether there was up-regulation of MMP-1, MMP-2, and MMP-9 was analyzed immunohistochemically. The frequency of the degradation of basement membrane underlying grade 1 pTa tumors was 0%, grade 2-3 pTa tumors 57.1%, and primary CIS lesions 83.3%. Nuclear over-accumulation of p53 was found in 48.3% and of mdm2 in 23.3% of the primary tumors. In pTa-pT1 carcinomas, nuclear staining of p53, mdm2, or both was highly correlated with degradation of the basement membrane underlying carcinomas (p = 0.00002). In the CIS lesions, the association of p53 nuclear staining with the destruction of type IV collagen expression was of borderline significance (p = 0.03). When mdm2 overexpression was co...Continue Reading
References
Feb 1, 1978·The Biochemical Journal·D E WoolleyJ M Evanson
Jun 22, 1979·Urological Research·G Wirl, J Frick
Nov 1, 1976·The Journal of Urology·A F AlthausenJ J Daly
Nov 1, 1992·The Journal of Urology·T HabuchiO Yoshida
Jun 26, 1992·Cell·J MomandA J Levine
Nov 1, 1991·Bone and Mineral·J A HoylandA J Freemont
Dec 15, 1990·Cancer·R F SchapersF T Bosman
Jun 1, 1987·British Journal of Cancer·N DaherP Burtin
Dec 1, 1987·British Journal of Urology·I G ConnC J Hilton
Apr 19, 1973·Clinica Chimica Acta; International Journal of Clinical Chemistry·H Trybuchowski
Mar 6, 1980·Nature·L A LiottaS Shafie
Jan 1, 1996·The Journal of Urology·H SekineH Ohshima
Jan 1, 1994·Virchows Archiv : an International Journal of Pathology·W I de BoerT H van der Kwast
Nov 1, 1994·Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology·F KimuraH Nakamura
Sep 7, 1994·Journal of the National Cancer Institute·P LianesC Cordon-Cardo
Sep 7, 1994·Journal of the National Cancer Institute·T HabuchiO Yoshida
Apr 6, 1994·Journal of the National Cancer Institute·M DrobnjakC Cordon-Cardo
Nov 1, 1993·British Journal of Cancer·Y SoiniK Vähäkangas
Apr 1, 1996·Journal of Cellular Physiology·G M GrantR J Klebe
Citations
Sep 17, 2008·Cancer Research·John M LamarC Michael DiPersio
Jun 9, 2000·The Journal of Investigative Dermatology·E ToschiM C Capogrossi
May 20, 2008·Oral Oncology·Shiang-Fu HuangLing-Ling Hsieh
Dec 15, 2005·International Journal of Urology : Official Journal of the Japanese Urological Association·Shuichi KamijimaHaruo Ito
Jan 31, 2004·Annals of the New York Academy of Sciences·Hui WangRuiwen Zhang
Mar 19, 1999·The Journal of Urology·E OzdemirO Yoshida
Aug 2, 2012·ISRN Urology·O Rodriguez FabaF J Vizoso
Apr 21, 1998·Japanese Journal of Cancer Research : Gann·Y KakehiO Yoshida
Jan 24, 1998·Japanese Journal of Cancer Research : Gann·T AkaoO Yoshida
May 16, 2001·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·K R LeiteL H Camara-Lopes
Oct 13, 2006·Current Opinion in Urology·S B Malkowicz
Feb 7, 2001·The Journal of Biological Chemistry·Y SunH S Cheung
May 30, 2019·Proceedings of the National Academy of Sciences of the United States of America·Jin BaiZhen-Qiang Pan
Oct 31, 2002·Cancer·Alessandro FranchiOreste Gallo
Mar 25, 2014·Cancer Discovery·Emily PowellHelen Piwnica-Worms
May 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gangqiao ZhouFuchu He
Jun 11, 2021·Annals of Diagnostic Pathology·Mariana Bonjiorno MartinsLaura Sterian Ward